Replies to post #2457 on Petlife Pharmaceuticals Inc. (PTLF)

[ProTrader4000]

PetLife Pharmaceuticals, Inc. (otcqb:PTLF) a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, announces new name and branding strategy in preparation of beginning the FDA process of its core product Escozine for Pets.